Pountos Ippokratis, Panteli Michalis, Walters Gavin, Bush Dudley, Giannoudis Peter V
Academic Department of Trauma and Orthopaedics, Leeds General Infirmary, Clarendon Wing Level A, Great George Street, Leeds, LS1 3EX, UK.
University of Leeds, Leeds, UK.
Drugs R D. 2016 Mar;16(1):19-34. doi: 10.1007/s40268-015-0119-3.
Epidural corticosteroid injections (ESIs) have been used for several decades and now represent the most common intervention performed for the management of back pain with a radicular component. However, several reports have presented devastating complications and adverse effects, which fuelled concerns over the risk versus clinical effectiveness. The authors offer a comprehensive review of the available literature and analyse the data derived from studies and case reports.
Studies were identified by searching PubMed MEDLINE, Ovid MEDLINE, EMBASE, Scopus, Google Scholar and the Cochrane Library to retrieve all available relevant articles. Publications from the last 20 years (September 1994 to September 2014) were considered for further analysis. Studies selected were English-language original articles publishing results on complications related to the technique used for cervical and lumbar ESIs. The studies had to specify the approach used for injection. All studies that did not fulfil these eligibility criteria were excluded from further analysis.
Overall, the available literature supports the view that serious complications following injections of corticosteroid suspensions into the cervical and lumbar epidural space are uncommon, but if they occur they can be devastating.
The true incidence of such complications remains unclear. Direct vascular injury and/or administration of injectates intra-arterially represent a major concern and could account for the vast majority of the adverse events reported. Accurate placement of the needle, use of a non-particulate corticosteroid, live fluoroscopy, digital subtraction angiography, and familiarisation of the operator with contrast patterns on fluoroscopy should minimise these risks. The available literature has several limitations including incomplete documentation, unreported data and inherent bias. Large registries and well-structured observational studies are needed to determine the true incidence of adverse events and address the safety concerns.
硬膜外皮质类固醇注射(ESIs)已应用数十年,目前是治疗伴有神经根症状的背痛最常用的干预措施。然而,有几份报告呈现了严重的并发症和不良反应,引发了对风险与临床疗效的担忧。作者对现有文献进行了全面综述,并分析了来自研究和病例报告的数据。
通过检索PubMed MEDLINE、Ovid MEDLINE、EMBASE、Scopus、谷歌学术和Cochrane图书馆来识别研究,以检索所有可用的相关文章。考虑对过去20年(1994年9月至2014年9月)发表的文献进行进一步分析。所选研究为发表关于颈椎和腰椎ESIs相关技术并发症结果的英文原创文章。这些研究必须明确注射所采用的方法。所有不符合这些纳入标准的研究均被排除在进一步分析之外。
总体而言,现有文献支持这样的观点,即向颈椎和腰椎硬膜外间隙注射皮质类固醇混悬液后的严重并发症并不常见,但如果发生则可能是灾难性的。
此类并发症的真实发生率仍不清楚。直接血管损伤和/或动脉内注射药物是一个主要问题,可能是所报告的绝大多数不良事件的原因。准确的针放置、使用非颗粒状皮质类固醇、实时荧光透视、数字减影血管造影以及使操作者熟悉荧光透视下的造影模式应能将这些风险降至最低。现有文献存在若干局限性,包括记录不完整、未报告的数据和内在偏差。需要大型登记处和结构良好的观察性研究来确定不良事件的真实发生率并解决安全问题。